Harbin Gloria Pharmaceuticals Co., Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 681.17 million compared to CNY 774.21 million a year ago. Revenue was CNY 681.17 million compared to CNY 774.21 million a year ago.

Net income was CNY 20.06 million compared to CNY 0.998263 million a year ago. Basic earnings per share from continuing operations was CNY 0.0091 compared to CNY 0.0005 a year ago. Diluted earnings per share from continuing operations was CNY 0.0091 compared to CNY 0.0005 a year ago.